55. Relapsing polychondritis Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 8 Drugs : 10 - (DrugBank : 9) / Drug target genes : 12 - Drug target pathways : 101

Drugs and their primary sponsors and trial info
Abatacept
   Benaroya Research Institute
      2011   Phase 1   NCT01272856   United States;
Ciclosporin
   St. Marianna University School of Medicine
      2010   -   JPRN-UMIN000003869   Japan;
DIMENSION
   St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
      2011   -   JPRN-UMIN000006950   Japan;
Infliximab
   Cambridge University Hospitals NHS Foundation Trust
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom;
Methotrexate
   St. Marianna University School of Medicine
      2010   -   JPRN-UMIN000003869   Japan;
Rituximab
   Cambridge University Hospitals NHS Foundation Trust
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom;
Tiotropium
   St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
      2011   -   JPRN-UMIN000006950   Japan;
Tocilizumab
   Cambridge University Hospitals NHS Foundation Trust
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom;
   Children's Hospital of Eastern Ontario
      2010   -   NCT01041248   Canada;
   McMaster Children's Hospital
      2010   Phase 2   NCT01104480   Canada;